Colorectal Cancer France Drug Forecasts and Treatment Analysis to 2020

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies

The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies

  • $ 3 013
  • Industry report
  • by Visiongain
  • July 2014
  • 208 pages

Report Details Where is the prostate cancer therapeutics market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 208-page report provides 160 tables, charts, and graphs. Our new study lets you assess leading drugs ...

Industries: Therapy | Countries: United States, World, South Korea, Europe, Brazil, Mexico, Italy, Japan, India, China, United Kingdom, Spain, Russian Federation, France, Germany

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • by GBI Research
  • July 2014
  • 72 pages

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to ...

Industries: Therapy | Countries: France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 60 pages

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • by GBI Research
  • June 2014
  • 112 pages

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, “Glioblastoma Multiforme Therapeutics ...

Industries: Therapy | Countries: World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 68 pages

Summary Chiesi Farmaceutici SpA (Chiesi) is a research focused pharmaceutical company. The company researches, develops and distributes pharmaceutical products with particular focus on respiratory, cardiovascular, and rare diseases. Its products include Atimos, Bramitob, Clenil, Curosurf, Foster, Iperten, ...

Industries: Therapy | Countries: World, Italy, Europe, United Kingdom, North America, United States, Czech Republic, France

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 3 500
  • Industry report
  • by GBI Research
  • April 2014
  • 122 pages

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics ...

Industries: Therapy | Countries: World, Japan, Canada, Europe, United States, Spain, Italy, France, Germany, United Kingdom, North America

Global Hormone Replacement Therapy (HRT) Industry

Global Hormone Replacement Therapy (HRT) Industry

  • $ 4 950
  • Industry report
  • by Global Industry Analysts
  • January 2014
  • 180 pages

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. ...

Industries: Therapy | Countries: World, United States, Canada, Europe, United Kingdom, France, Italy, Germany, Spain, North America, Japan

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2011 - 2020)

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2011 - 2020)

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • December 2013
  • 157 pages

The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential as the incidence rate of the disease is increasing all over the globe. The incidence of acute lymphocytic/lymphoblastic leukemia is higher in children from 0 to 14 years than in those aged 15 years and above. However, ...

Industries: Therapy | Countries: Canada, Spain, Italy, France, Germany, Japan, United States, Europe, World, North America

Hyperuricemia - Pipeline Review, H2 2013

Hyperuricemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • November 2013
  • 51 pages

Hyperuricemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hyperuricemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hyperuricemia, complete with latest updates, and special ...

Industries: Therapy | Countries: World, Japan, Canada, France, South Korea

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation

  • $ 3 500
  • Industry report
  • by GBI Research
  • October 2013
  • 90 pages

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation Summary GBI Research has released its pharmaceuticals report, "Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying ...

Industries: Therapy | Countries: World, Japan, United States, Spain, Italy, France, Germany

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.